Spain · Delayed Price · Currency is EUR Naturhouse Health Statistics
Total Valuation
BME:NTH has a market cap or net worth of EUR 120.60 million. The enterprise value is 112.53 million.
| Market Cap | 120.60M |
| Enterprise Value | 112.53M |
Important Dates
The next estimated earnings date is Friday, December 18, 2026.
| Earnings Date | Dec 18, 2026 |
| Ex-Dividend Date | Nov 4, 2026 |
Share Statistics
BME:NTH has 60.00 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 60.00M |
| Shares Outstanding | 60.00M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 0.08% |
| Owned by Institutions (%) | 0.42% |
| Float | 13.10M |
Valuation Ratios
The trailing PE ratio is 14.43.
| PE Ratio | 14.43 |
| Forward PE | n/a |
| PS Ratio | 2.77 |
| PB Ratio | 8.11 |
| P/TBV Ratio | 8.35 |
| P/FCF Ratio | 11.56 |
| P/OCF Ratio | 11.70 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.02, with an EV/FCF ratio of 10.81.
| EV / Earnings | 13.49 |
| EV / Sales | 2.59 |
| EV / EBITDA | 10.02 |
| EV / EBIT | 10.46 |
| EV / FCF | 10.81 |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.25.
| Current Ratio | 1.56 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 0.34 |
| Debt / FCF | 0.36 |
| Interest Coverage | 189.68 |
Financial Efficiency
Return on equity (ROE) is 41.83% and return on invested capital (ROIC) is 111.32%.
| Return on Equity (ROE) | 41.83% |
| Return on Assets (ROA) | 18.35% |
| Return on Invested Capital (ROIC) | 111.32% |
| Return on Capital Employed (ROCE) | 55.59% |
| Weighted Average Cost of Capital (WACC) | 6.34% |
| Revenue Per Employee | 267,345 |
| Profits Per Employee | 51,226 |
| Employee Count | 168 |
| Asset Turnover | 1.22 |
| Inventory Turnover | 4.45 |
Taxes
In the past 12 months, BME:NTH has paid 2.95 million in taxes.
| Income Tax | 2.95M |
| Effective Tax Rate | 25.50% |
Stock Price Statistics
The stock price has decreased by -11.40% in the last 52 weeks. The beta is 0.41, so BME:NTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -11.40% |
| 50-Day Moving Average | 2.46 |
| 200-Day Moving Average | 2.51 |
| Relative Strength Index (RSI) | 19.39 |
| Average Volume (20 Days) | 57,841 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:NTH had revenue of EUR 44.91 million and earned 8.61 million in profits. Earnings per share was 0.14.
| Revenue | 44.91M |
| Gross Profit | 31.84M |
| Operating Income | 10.81M |
| Pretax Income | 11.55M |
| Net Income | 8.61M |
| EBITDA | 10.96M |
| EBIT | 10.81M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 11.96 million in cash and 3.88 million in debt, with a net cash position of 8.08 million or 0.13 per share.
| Cash & Cash Equivalents | 11.96M |
| Total Debt | 3.88M |
| Net Cash | 8.08M |
| Net Cash Per Share | 0.13 |
| Equity (Book Value) | 15.31M |
| Book Value Per Share | 0.26 |
| Working Capital | 5.93M |
Cash Flow
In the last 12 months, operating cash flow was 10.61 million and capital expenditures 128,000, giving a free cash flow of 10.74 million.
| Operating Cash Flow | 10.61M |
| Capital Expenditures | 128,000 |
| Depreciation & Amortization | 150,000 |
| Net Borrowing | -3.67M |
| Free Cash Flow | 10.74M |
| FCF Per Share | 0.18 |
Margins
Gross margin is 70.90%, with operating and profit margins of 24.07% and 19.16%.
| Gross Margin | 70.90% |
| Operating Margin | 24.07% |
| Pretax Margin | 25.72% |
| Profit Margin | 19.16% |
| EBITDA Margin | 24.41% |
| EBIT Margin | 24.07% |
| FCF Margin | 23.91% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 9.95%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 9.95% |
| Dividend Growth (YoY) | -16.67% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 225.83% |
| FCF Payout Ratio | 113.12% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 9.86% |
| Earnings Yield | 6.93% |
| FCF Yield | 8.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:NTH has an Altman Z-Score of 8.58 and a Piotroski F-Score of 5.
| Altman Z-Score | 8.58 |
| Piotroski F-Score | 5 |